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Summary
van der Woude syndrome (VWS), which has been
mapped to 1q32-41, is characterized by pits and/or si-
nuses of the lower lip, cleft lip/palate (CL/P), cleft palate
(CP), bifid uvula, and hypodontia (H). The expression
of VWS, which has incomplete penetrance, is highly var-
iable. Both the occurrence of CL/P and CP within the
same genealogy and a recurrence risk !40% for CP
among descendants with VWS have suggested that the
development of clefts in this syndrome is influenced by
modifying genes at other loci. To test this hypothesis,
we have conducted linkage analysis in a large Brazilian
kindred with VWS, considering as affected the individ-
uals with CP, regardless of whether it is associated with
other clinical signs of VWS. Our results suggest that a
gene at 17p11.2-11.1, together with the VWS gene at
1p32-41, enhances the probability of CP in an individual
carrying the two at-risk genes. If this hypothesis is con-
firmed in other VWS pedigrees, it will represent one of
the first examples of a gene, mapped through linkage
analysis, which modifies the expression of a major gene.
It will also have important implications for genetic coun-
seling, particularly for more accurately predicting re-
currence risks of clefts among the offspring of patients
with VWS.
Introduction
van der Woude syndrome (VWS; [MIM 119300]) is a
rare autosomal dominant orofacial disorder caused by
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a gene mapped to 1q32-41, with a penetrance of
89%–90% (Burdick et al. 1985; Murray et al. 1990).
The cardinal features of this syndrome are pits and/or
sinuses of the lower lip (lip pits [LP]), which are present
in ∼80% of VWS-gene carriers. These pits are associated
with clefts in approximately half of these carriers: two-
thirds of those with clefts have cleft lip and/or palate
(CL/P), and one-third have cleft palate alone (CP). Hy-
podontia (H) is present in ∼20%–30% of gene carriers
and may occasionally represent the sole expression of
the gene. Microforms that represent a mild expression
of the gene may include a verrucous eminence in the
lower lip, submucous CP, and bifid uvula (BU) (Cervenka
et al. 1967; Burdick et al. 1985; Schinzel and Klauser
1986). The occurrence of CP and CL/P within the same
family or even the same sibship is very intriguing, since
these two malformations classically have been regarded
as two separate embryological events (Fraser 1970). It
has been observed that the risk for CP in a child is
significantly higher when the parent has both LP and
CL/P than when the parent has LP only (Cervenka et al.
1967; Burdick et al. 1985). An association between the
type of cleft in the parent and that in the offspring has
also been shown (Shprintzen et al. 1980; Burdick et al.
1985). In order to explain these findings, it has been
proposed that individuals who carry the gene for VWS
are also subject to any multifactorial influences (envi-
ronmental and genetic) contributing to clefting. Also, the
development of clefts in persons carrying a “lip pit”
major gene may depend on the presence of modifying
genes at other loci (Cervenka et al. 1967; Shprintzen et
al. 1980; Burdick et al. 1985). However, the identifi-
cation of modifying genes in any genetic disorder re-
quires the analysis of large pedigrees, which are usually
very rare, particularly if more than one susceptibility
locus is involved.
We have identified a large Brazilian family with VWS
in which the phenotypic expression among the patients
ranges from complete bilateral CL/P with LP to LP only.
One branch of this family, in which 5 of 16 sibs have
CP (involving both soft and hard palate), constitutes a
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Figure 1 Haplotype analysis for the most informative markers from the 1q32-41 region, that showed linkage to the VWS gene. Only the
individuals who were available for DNA studies were included. The at-risk haplotype for VWS is boxed.
unique opportunity to search for modifying genes that
contribute to the development of CP. In an attempt to
achieve this goal, linkage analysis was performed in this
particular sibship using a different approach; it counted
as affected only those who have CP, regardless of




This family was ascertained at the Department of Plas-
tic Surgery of the University of Sa˜o Paulo, Brazil. The
pedigree, as far as it could be traced, contains 75 mem-
bers in four generations: 25 clinically affected individ-
uals and 50 apparently normal ones. Thirty-one DNA
samples were obtained for genetic analysis (14 from nor-
mal and 17 from affected individuals), and the following
individuals were clinically examined: II-3, II-4, III-1, III-
3–III-21, and IV-1–IV-8. The clinical classification of the
remaining cases was based on information from more
than one relative of the family. As indicated in figure 1,
the clinical status of I-1 and I-2 was unknown.
Methods
Genotype.—Genomic DNA was extracted from
whole blood according to standard techniques (Miller
et al. 1988). Linkage to the VWS gene was tested with
six polymorphic microsatellite markers from 1q32-41
(D1S245, D1S471, D1S491, D1S205, D1S217, and
D1S178; the order of these markers was based on the
work of Schutte et al. [1996] and Dib et al. [1996]).
To identify in this genealogy a potential CP suscep-
tibility locus that is not allelic to VWS, we performed a
linkage search in the sibship (III-1–III-16), segregating
CP as the major clinical sign, independently of the pres-
ence of other clinical features of VWS. This criterion
was adopted because of our poor understanding of the
genetic causes of each of the malformations of this syn-
drome; it is still unclear whether the malformations have
different embryological origins. Because we can not yet
distinguish clinically between the dependent and the in-
dependent occurrence of CL and CP, all individuals with
CL and CP (hard and soft palate) were included as af-
fected. In addition, although it is known that BU may
be a consequence of CP, Meskin et al. (1965) showed
that in the normal population this malformation may
occur in isolation, suggesting that its occurrence may
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Figure 2 A, Haplotype with markers from the 17p11.2-11.1 region in the sibship III-1–III-16. The at-risk haplotype for the CP-predisposing
locus in the family is boxed. The order and interlocus distances among the markers are from the Ge´ne´thon map (Dib et al. 1996). Only
individuals with CP, independently of the presence of other clinical features of VWS, are indicated as affected (blackened circles). B, Haplotype
with the most informative markers from the 17p11.2-11.1 region, in the total family. The at-risk haplotype for the CP-predisposing locus in
the family is boxed. Only individuals with CP, independently of the presence of other clinical features of VWS, are indicated as affected (blackened
circles).
have a different etiology; therefore, patients who had
only BU were not classified as affected. In the sibship
selected for linkage analysis, there are seven phenotyp-
ically normal individuals and nine patients with at least
one clinical feature of VWS: two with CP only, two with
CP and LP, one with CL and CP, and four with LP only.
For the search of the modifying locus, we considered as
affected those five individuals with CP and considered
as normal persons the remaining eleven individuals. In
a first-stage search, we tested 43 polymorphic markers
from genes and/or chromosomal regions that are can-
didates for the Stickler phenotype (COL2A1, COL11A1,
and COL11A2) and for the development of nonsyn-
dromic CL/P and CP, as shown in table 2. In a second
screening set, we analyzed 130 microsatellites, spaced
∼10–20 cM apart, across 12 autosomes (chromosomes
5 and 12–22). A modification of the PCR-based DNA-
pooling strategy was used (Arnheim et al. 1985): 5 in-
dividuals considered as affected were analyzed sepa-
rately and equal amounts of DNA from the 11 sibs clas-
sified as normal were used as a DNA control pool. If a
shared allele was observed among the patients but at
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Table 1
Two-point Linkage Analysis, Between the Most Informative Chromosome 1 Markers and the Disease Gene
CYTOGENETIC
LOCALIZATION LOCUS
LOD SCORE AT v 
MAXIMUM v
MAXIMUM
LOD SCORE0 .01 .05 .1 .2 .3 .4
1q32-41 D1S245 .32 3.64 4.12 4.05 3.39 2.39 1.14 .06 4.13
1q32-41 D1S471 1.75 1.68 2.28 2.38 2.07 1.45 .51 .09 2.38
1q32-41 D1S491 .32 3.64 4.12 4.05 3.39 2.39 1.14 .06 4.13
1q32-41 D1S205 2.36 2.32 2.15 1.94 1.49 1.01 .51 0 2.36
lower intensity than in the DNA control pool, all the
individuals from this sibship were then tested for this
marker. Evidence of linkage was considered when a LOD
score1 was observed in this sibship (the Multiple Scle-
rosis Group 1996). In this case, all the genealogy was
tested, and, again, we considered as affected only those
individuals with CP, regardless of whether it was asso-
ciated with other clinical signs of the syndrome (fig. 2).
DNA amplification for the individual cases was done
with 60 ng of DNA in a 10-ml PCR containing 10 mM
Tris-HCl pH 9.0, 1.5 mM MgCl2, 50 mM KCl; 0.01%
gelatin; 0.1% Triton; 200 mM each of dATP, dTTP, and
dGTP; 2.5 mM dCTP; 7.5 # 104 mCi of [P32]-dCTP;
4.0 pmol of each primer; and 0.2 U of Taq DNA poly-
merase (HT Biotechnology LTD). The DNA control pool
contained 60 ng of DNA from each of the 11 individuals
classified as normal, and the PCR conditions were the
same as those used for individual cases.
Statistical analysis.—Two-point linkage analysis
was performed by use of the MLINK program of the
LINKAGE package, version 5.1 (Lathrop et al. 1984).
The frequency of the VWS gene, with autosomal dom-
inant inheritance, was assumed to be .001 with a 90%
penetrance. For the modifying locus, we also inferred an
autosomal dominant inheritance, on the basis of the pro-
posed models of inheritance for clefts (Hecht et al. 1991;
Marazita et al. 1992). Two allele frequencies were con-
sidered for this putative modifier, .01 and .001, with
.50–.90 as the range of penetrance values. Equal allele
frequencies were used for all the marker loci; however,
allele frequencies for the most informative markers that
showed evidence of linkage (D17S1843, D17S953,
D17S1824, D17S1873, and D17S1800) were estimated
in 80 chromosomes from unrelated healthy Brazilians.
Recombination frequencies were assumed to be equal in
males and females.
Results
Clinical Characterization of the Genealogy and
Linkage Analysis to the VWS Locus
Among the 75 offspring of the ancestral couple, 25
had one or more manifestations of the syndrome: 5 have
the classic combination of LP and CL/P, 10 have LP only,
4 have CP only, 2 have bilateral CL/P, 2 have BU and
LP, and 2 have only BU.
Linkage analysis with six markers from the 1q32-41
region, performed in 31 members of the genealogy (14
normal individuals and 17 patients with VWS), con-
firmed linkage to the VWS locus, as detailed in table 1
and summarized in figure 1. Interestingly, we observed
two individuals (III-2 and III-16) who have inherited
from their affected father the entire at-risk haplotype for
VWS but who are themselves phenotypically normal.
Linkage Analysis for the Mapping of a Predisposing
Locus for CP in Patients with VWS
Considering now as affected patients only those who
have CP, regardless of whether it is associated with other
clinical manifestations of VWS (sibs III-1–III-16), no ev-
idence of linkage was observed with any of the 43 mi-
crosatellites tested nearby or within 16 candidate genes
for nonsyndromic CL/P, CP, and the Stickler phenotype
(table 2). Subsequently, we performed a partial ge-
nomewide linkage search, using 130 mapped autosomal
microsatellite markers in this sibship of interest. No ev-
idence for linkage with any of the other markers was
observed, except for the marker D17S1824, for which
all five women affected by CP shared an allele that was
underrepresented in the control pool. Therefore, all the
individual members of this sibship were genotyped. The
highest LOD scores (1.92 and 1.95; recombination frac-
tion [v] 0) were observed with 70% and 80% pene-
trances, respectively, and, therefore, we considered these
values of penetrance for further analysis (table 3). Thir-
teen additional markers from this 17p11.2-11.1 region
were analyzed (D17S520, D17S799, D17S1843,
D17S953, D17S793, D17S261, D17S1873, D17S1800,
D17S1880, D17S798, D17S1850, D17S1833, and
D17S1872). Positive LOD scores were obtained for most
of these markers (data not shown), and a common hap-
lotype spanning a 26-cM region was observed in all pa-
tients with CP (figure 2A). The LOD scores for the most
informative markers (D17S1843, D17S953, D17S1824,
D17S1873, and D17S1800) are shown in table 3; similar
values were obtained independently of the estimated fre-
quency for the modifier locus—that is, .01 or .001.
The most informative markers (D17S1843, D17S953,
D17S1824, D17S1873, and D17S1800) were also gen-
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Table 2
Candidate Genes and/or Chromosomal Regions for the Development of CL/P and CP, Tested in the
Family with VWS
Candidate Gene and/or
Chromosomal Region Location Markers Used
Growth factors:
GR1 5q11-q14 D5S806, D5S428, D5S815, D5S107
TGFA 2p13 D2S170, D2S177, D2S405
RARA 17q21.1 D17S250, D17S579
BCL3 19q13.1 D19S47, APOC2
FGFA 5q31.3-33/5q33.3-qter D5S209, D5S422, D5S400, D5S211
TGFB1 19q13.1 D19S433, D19S224,D19S178
TGFB3 14q23-q24 D14S52, D14S298, D14S53
Homeobox genes:
HOX2B 17q21-2 HOXB2, D17S809
HOX7 (MSX1) 4q16.1-.3 HOX7, D4S412, D4S394, D4S403
HOX8 (MSX2) 5q35 D5S408
Extracellular matrix proteins:
COL2A1 12q12-q13.2 D12S59, D12S85
COL9A1 6q12-q14 D6S254, D6S251
COL11A1 1p21 D1S223, D1S206, D1S2896, D1S2671
COL11A2 6p21.2 D6S105, D6S89, D6S276
Chromosomal regions 4q25-4q31.3 D4S175, D4S192
6p24.3 D6S105, D6S89
otyped in the whole family (fig. 2B). For a penetrance
of 70%, a peak LOD score of 2.05 at was observedv  0
for the marker D17S1824, also suggesting linkage (table
4). Haplotype analysis (fig. 2B) showed that five indi-
viduals, apparently without CP, have inherited simul-
taneously the at-risk haplotypes for CP (17p11.2-11.1)
as well as for VWS (1q32-41): one has LP associated
with CL (IV-1), one has LP only (IV-3), one has severe
hypernasal speech and BU (II-4), and two have normal
phenotypes (sibs III-2 and III-16). It is also important
to notice that the hypernasal speech in patient II-4, who
has refused to be examined, can be due to submucous
CP.
Discussion
The Mendelian concept of monogenic disease causa-
tion appears to be increasingly untenable for a growing
number of developmental errors. There are many ex-
amples showing that well-delineated clinical entities can
be genetically heterogeneous and that distinct mutations
in a particular gene may result in fundamental clinical
differences. In addition, examples of identical mutations
resulting in highly variable phenotypes have been shown
for many genetic disorders. However, the underlying
mechanisms for these findings are poorly understood.
Many hypotheses have been proposed—such as epige-
netic genes and interactions among different genes (Wolf
1997). Thein et al. (1994) and Craig et al. (1996) have
demonstrated that the heterocellular hereditary persist-
ence of fetal hemoglobin (HPFH) is influenced by several
genetic modifiers and have mapped a distinct locus to
6p, unlinked to the b-globin gene complex. This new
locus was identified through linkage analysis in a very
large kindred of Asian origin. Interestingly, the higher
levels of HPFH were segregating with this chromosome
region in one branch of the genealogy but not in the
other, suggesting the existence of still other modifier loci
in the same family. The analysis of this large pedigree
demonstrates that the study of single families or even of
a single sibship can be very important in the search for
susceptibility genes, since such an approach increases the
likelihood that genetic homogeneity will be found. In
orofacial clefts (OFC), several studies have supported
the hypothesis of two or more genes simultaneously in-
volved in their etiology (Farral et al. 1992; Clementi et
al. 1995). Recently, Pezzetti et al. (1998) have demon-
strated an interactive effect of two disease loci, mapping
to 2p13 and to 6p23, that are involved in nonsyndromic
OFC malformations in some families.
The Brazilian family with VWS described here is of
particular interest, since it has a great number of affected
individuals with CP in only one sibship and, therefore,
is uniquely well-suited to the search for a modifying (or
susceptibility) locus through linkage analysis. The partial
genome scan in this sibship showed that all affected pa-
tients with CP share a common haplotype both for VWS
and for the 17p11.2-11.1 regions. Moreover, if we clas-
sify patient II-4 (who has severe hypernasal speech) as
affected, the estimated LOD score of 2.05 at forv  0
the marker D17S1824 increases to 2.89 at withv  0
penetrance of 70%.
If we consider all the individuals with the VWS at-
risk haplotype in the present genealogy, and if we include
II-4 as affected, the estimated penetrance for CP is 6/19
(31.5%); however, if we consider the presence of both
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Table 3
Two-point Linkage Analysis, between Each 17p Most Informative




LOD SCORE AT v 
0 .01 .05 .1 .2 .3 .4
50%:
D17S1843 1.68 1.65 1.51 1.34 .96 .56 .18
D17S953 1.68 1.65 1.51 1.34 .96 .56 .18
D17S1824 1.67 1.64 1.51 1.33 .96 .56 .18
D17S1873 1.67 1.64 1.51 1.33 .96 .56 .18
D17S1800 1.67 1.64 1.51 1.33 0.96 .56 .18
60%:
D17S1843 1.81 1.78 1.65 1.47 1.07 .64 .21
D17S953 1.81 1.78 1.65 1.47 1.07 .64 .21
D17S1824 1.81 1.78 1.64 1.46 1.07 .63 .21
D17S1873 1.81 1.78 1.64 1.46 1.07 .63 .21
D17S1800 1.81 1.78 1.64 1.46 1.07 .63 .21
70%:
D17S1843 1.92 1.89 1.76 1.60 1.19 .72 .25
D17S953 1.92 1.89 1.76 1.60 1.19 .72 .25
D17S1824 1.92 1.89 1.76 1.59 1.18 .71 .24
D17S1873 1.92 1.89 1.76 1.59 1.18 .71 .24
D17S1800 1.92 1.89 1.76 1.59 1.18 .71 .24
80%:
D17S1843 1.95 1.93 1.84 1.69 1.30 .82 .29
D17S953 1.95 1.93 1.84 1.69 1.30 .82 .29
D17S1824 1.95 1.93 1.83 1.68 1.29 .81 .28
D17S1873 1.95 1.93 1.83 1.68 1.29 .81 .28
D17S1800 1.95 1.93 1.83 1.68 1.29 .81 .28
90%:
D17S1843 1.76 1.78 1.79 1.72 1.40 .92 .35
D17S953 1.76 1.78 1.79 1.72 1.40 .92 .35
D17S1824 1.76 1.78 1.79 1.72 1.39 .90 .33
D17S1873 1.76 1.78 1.79 1.72 1.39 .90 .33
D17S1800 1.76 1.78 1.79 1.72 1.39 .90 .33
Table 4
Two-point Linkage Analysis, between Each 17p Most Informative
Marker and the Disease Locus, in All Available Members of the
Family, with 70% and 80% Penetrance
PENETRANCE
AND LOCUS
LOD SCORE AT v 
0 .01 .05 .1 .2 .3 .4
70%:
D17S1843 1.44 1.44 1.41 1.35 1.12 .77 .32
D17S953 1.10 1.15 1.26 1.28 1.14 .81 .35
D17S1824 2.05 2.04 1.96 1.83 1.48 1.00 .43
D17S1873 1.13 1.14 1.17 1.16 1.02 .72 .30
D17S1800 1.78 1.78 1.73 1.64 1.34 .93 .39
80%:
D17S1843 1.17 1.19 1.25 1.26 1.13 .81 .35
D17S953 .67 0.79 1.06 1.19 1.16 .87 .39
D17S1824 1.86 1.87 1.88 1.83 1.55 1.10 .49
D17S1873 .61 .67 .84 .96 .96 .74 .33
D17S1800 1.55 1.58 1.63 1.61 1.40 1.00 .45
at-risk haplotypes, the estimated penetrance for CP in-
creases to 6/10 (60%). These observations suggest that
the 17p haplotype increases the penetrance of CP in this
family, although it does not explain the association of
these two malformations in all the patients with VWS.
In this regard, it is intriguing that two of five patients
without CP who have both “at-risk” haplotypes are also
nonpenetrant for the VWS gene. It is also interesting
that four of these five nonpenetrant individuals are
males, whereas all the other individuals with CP who
have both at-risk haplotypes are females. These obser-
vations further suggest that other genetic or environ-
mental factors may contribute to the development of the
abnormal phenotype. Indeed, the effect of nongenetic
factors for the manifestations of clefts in VWS has been
illustrated by the observation of a pair of MZ twins with
VWS who are discordant for cleft lip but not for LP
(Cervenka et al. 1967). Another important point to be
addressed is the lack of the 17p at-risk haplotype in the
individuals with only BU. However, as reported by Mes-
kin et al. (1965), this condition—the incidence of which
is ∼1% in whites and ∼10% in Native Americans and
Japanese Americans, has a frequency of 18% in sibs and
parents of affected persons. These observations suggest
that this condition is not rare and that it may occur
independently of alterations in the palate.
The penetrance for CP in the present genealogy is
comparable to the estimates in the literature, which vary
from 15% to ∼40% among families with VWS (Cer-
venka et al. 1967; Janku et al. 1980; Burdick et al. 1985).
This low penetrance for CP in the great majority of
families with VWS raises the possibility that 17p may
be a modifying locus that interacts with the 1q gene,
increasing the chance that an individual with both at-
risk chromosomes will develop cleft palate. Regarding
the frequency of this 17p modifier locus, there are two
possibilities. The first is that the 17p gene could be one
of many modifying loci contributing to CP; in this case,
the confirmation of these data in other families with
VWS will not be easy. Linkage analysis in many mul-
tifactorial diseases, such as schizophrenia, prostate can-
cer, and nonsyndromic CL/P and CP, have provided good
examples of positive findings in one data set that have
not been often replicated in other studies (Sherrington
et al. 1988; Murray 1995; Eeles et al. 1997; McIndoe
et al. 1997). Alternatively, the 17p gene represents a
more common modifying locus, and, in this case, the
study of other large families with VWS that are segre-
gating CP may confirm our findings. The observation of
relatively high (10%–44%) proportions of altered clefts
among patients with a deletion at 17p11.2 (Smith et al.
1986; Stratton et al. 1986; Greenberg et al. 1996) is
relevant to the present findings, further suggesting the
existence, in this region, of a gene predisposing to clefts.
Identifying and characterizing susceptibility or mod-
ifying loci is a difficult task, since the degree and type
of epistasis, or interaction among them, strongly influ-
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ence the chance of detecting such genes via a linkage-
analysis study. The difficulty is increased further because
these genes may vary among families and even among
different sibships within one genealogy. We are aware
that our findings should be interpreted with caution,
since the LOD scores obtained in the present study did
not meet the most stringent level of statistical signifi-
cance for linkage (Lander et al. 1995). However, these
results represent the first suggestion of a modifier locus
acting together with the VWS gene. The confirmation
of a CP-predisposing locus at 17p11.2-11.1, which de-
pends on further studies of other large families with
VWS and with multiple cases of CP, will be extremely
important for genetic counseling, particularly for more
accurately predicting the recurrence risks of clefts among
the offspring of patients with VWS.
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